The observed decreases in PRDM1/BLIMP1 and TNFRSF17/BCMA resulting from HDAC11 inhibition of IRF4 provide a reasonable explanation for the impaired plasma cell development and cytotoxic effects observed on MM cells. Here, IRF4 is linked to Miyoshi myopathy.